Selenium for Prevention of Adenomatous Colorectal Polyps
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Sponsor: National Cancer Institute (NCI)
Terminated
Concluded - Terminated by PI
Other terminated trials from National Cancer Institute (NCI)
This PHASE3 trial investigates Adenomatous Colorectal Polyps and Colorectal Cancer and is currently terminated or withdrawn. National Cancer Institute (NCI) leads this study, which shows 11 recorded versions since 2005 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE3
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE3
▶ Show 6 earlier versions
-
Oct 2019 — Jan 2021 [monthly]
Terminated PHASE3
-
Dec 2018 — Oct 2019 [monthly]
Terminated PHASE3
Status: Unknown Status → Terminated
-
Jun 2018 — Dec 2018 [monthly]
Unknown Status PHASE3
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
Feb 2017 — Feb 2018 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Jan 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- University of Arizona
For direct contact, visit the study record on ClinicalTrials.gov .